 The prevalence of substandard and falsified SF tuberculosis TB medications is widespread globally with estimates ranging from 15.2 percent to 40 percent. This is concerning because these medications can lead to increased resistance to TB treatments which can have serious implications for patient outcomes. This article was authored by Paul N. Newton and Patricia Tabonero.